IMPDH- und MPA-Messungen zur Klärung der Interaktionen zwischen Mycophenolat-Natrium und dem Protonenpumpeninhibitor Pantoprazol nach primärer orthotoper Herztransplantation
In this prospective study we investigated the impact of the proton pump inhibitor (PPI) pantoprazole on the bioavailability of mycophenolic acid (MPA) after oral administration of enteric-coated mycophenolate sodium (EC-MPS; Myfortic) in heart or lung transplant recipients. Previously we demonstrate...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Ludwig-Maximilians-Universität München
2013
|
| Subjects: | |
| Online Access: | http://edoc.ub.uni-muenchen.de/15945/1/Wolf_Christine.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-159458 |
